Found 7 matching trials
A Study to Evaluate Safety and Tolerability of CVL-231 (Emraclidine) in Adult Participants With Schizophrenia PHASE2 The primary purpose of this study is to assess the long-term safety and tol...
Show More Learn More & Join Trial
A Study to Assess Mass Balance, Pharmacokinetics, Metabolism, and Excretion of Emraclidine in Healthy Adult Male Participants PHASE1 The primary purpose of this study is to determine the mass balance, routes,...
Show More Learn More & Join Trial
A Study Evaluating the Pharmacokinetics and Relative Bioavailability of Emraclidine Immediate-Release Tablets in Healthy Adult Participants PHASE1 The purpose of this trial is to evaluate plasma concentrations of emraclidi...
Show More Location
Overland Park, Kansas
Learn More & Join Trial
A Trial of 10 and 30 mg Doses of CVL-231 (Emraclidine) in Participants With Schizophrenia PHASE2 This is a Phase 2, multicenter, randomized, double-blind, placebo-controlle...
Show More Location
Little Rock, Arkansas
Learn More & Join Trial
A Trial to Evaluate the Effects of Itraconazole and Carbamazepine on the Pharmacokinetics of Emraclidine and of Emraclidine on the Pharmacokinetics of Metformin in Healthy Adult Participants PHASE1 The primary purpose of the study is to evaluate the effect of itraconazole,...
Show More Location
Overland Park, Kansas
Learn More & Join Trial
A Trial of 15 and 30 mg Doses of CVL-231 (Emraclidine) in Participants With Schizophrenia PHASE2 This is a Phase 2, multicenter, randomized, double-blind, placebo-controlle...
Show More Location
Bentonville, Arkansas
Learn More & Join Trial
A Trial to Evaluate the Effect of Esomeprazole on the Pharmacokinetics of Emraclidine in Healthy Adult Participants PHASE1 The primary purpose of this study is to evaluate the potential of gastric p...
Show More Location
Dilworth, Minnesota
Learn More & Join Trial